Biofrontera's association is yet another value-enhancing development for Allegiance and an addition to its existing and growing portfolio of intellectual property that includes:
CM-X is a proprietary compound for treating and preventing diabetes and related cardiovascular conditions which reduces blood sugar, LDL cholesterol, triglicerides and vascular inflammation. CM-X has been formulated into a wide variety of every day foods and beverages such as Heart Chocolate-CM-X. The sales of Heart Chocolate have exceeded expectations and Heart Chocolate is featured in over 200 stores in Canada. For further information see http://www.heartchocolate.ca.
ZX-HDL Formulation is to be developed in partnership with a leading Canadian Cardiologist and Nutrasource Diagnostics Inc. to develop and test ZX in fish oil and Omega Formulas to increase HDL Cholesterol levels.
Allegiance's corporate development program of aggressive product development and continuous sourcing of intellectual property augments its goal of using natural ingredients to maximize profits and minimize risks; while dramatically reducing safety risks for both users as well as investors in its products.
Certain statements contained in this press release may be considered as
forward-looking. Such forward-looking statements are subject to risks and
uncertainties that could cause actual results to differ materially from
estimated or implied results. The TSX Venture Exchange has neither approved
nor disapproved the contents of this new release.
The TSX Venture Exchange has not reviewed and does not accept
responsibility FOR THE ADEQUACY OR ACCURACY FOR THIS PRESS RELEASE, W
|SOURCE Allegiance Equity Corporation|
Copyright©2008 PR Newswire.
All rights reserved